Sortino ratio is not yet available for ASD. This metric requires at least 12 months of historical daily returns to calculate. Check back once this data is available.
How it compares to other similar ETFs
The table compares Defiance Autism Impact ETF's Sortino Ratio with other ETFs in the Health & Biotech Equities category across multiple time periods, showing how ASD's risk-adjusted performance compares to similar funds.
Data shows 1-, 5-, and 10-year periods, plus each fund's all-time average, as of Jul 1, 2026.
| Symbol | Name | 1Y Sortino Ratio | 5Y Sortino Ratio | 10Y Sortino Ratio | All Time Sortino Ratio |
|---|---|---|---|---|---|
| BBC | Virtus LifeSci Biotech Clinical Trials ETF | 5.07 | |||
| SBIO | ALPS Medical Breakthroughs ETF | 4.58 | |||
| IHE | iShares U.S. Pharmaceuticals ETF | 4.39 | |||
| XBI | SPDR S&P Biotech ETF | 4.31 | |||
| FTXH | First Trust Nasdaq Pharmaceuticals ETF | 4.24 | |||
| PJP | Invesco Dynamic Pharmaceuticals ETF | 4.16 | |||
| LFSC | F/m Emerald Life Sciences Innovation ETF | 4.09 | |||
| CANC | Tema Oncology ETF | 4.06 | |||
| IBRN | iShares Neuroscience and Healthcare ETF | 4.01 | |||
| XPH | SPDR S&P Pharmaceuticals ETF | 3.88 | |||
| ASD | Defiance Autism Impact ETF | — |
Historical Sortino Ratio
The chart shows ASD's rolling Sortino ratio over time compared to your chosen benchmark. Rising trends indicate improving returns relative to downside risk, while declining trends may signal deteriorating risk-adjusted performance or increased volatility during market stress. Use multiple timeframes to distinguish short-term fluctuations from long-term patterns.
Identify market cycles by observing when ASD consistently outperforms (line above benchmark), underperforms (below benchmark), or aligns with the benchmark.
Loading charts...
IHow does ASD fit in your portfolio?
Add your other holdings to see your portfolio's Sortino Ratio and find out.
Analyze Your Portfolio